Amplification and Deletion of Topoisomerase IIα Associate with ErbB-2 Amplification and Affect Sensitivity to Topoisomerase II Inhibitor Doxorubicin in Breast Cancer-Reference-Cited by-同舟云学术

Amplification and Deletion of Topoisomerase IIα Associate with ErbB-2 Amplification and Affect Sensitivity to Topoisomerase II Inhibitor Doxorubicin in Breast Cancer

Published:2000-03 Issue:3 Volume:156 Page:839-847
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Järvinen Tero A.H.,Tanner Minna,Rantanen Virpi,Bärlund Maarit,Borg Åke,Grénman Seija,Isola Jorma

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference59 articles.

1. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization;Pauletti;Oncogene,1996

2. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas;Press;J Clin Oncol,1997

3. Should selection of adjuvant chemotherapy for patients with breast cancer be based on erbB-2 status?;Clark;J Natl Cancer Inst,1998

4. Response to mitoxantrone in advanced breast cancer: correlation with the expression of c-erbB-2 protein and glutathione S-transferases;Wright;Br J Cancer,1992

5. The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers;Ravdin;Gene,1995

Cited by 329 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and in silico assessment of quinoxaline platinum complexes as ATPase competitive topoisomerase inhibitors;2024-09-11

2. Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial;Breast Cancer Research and Treatment;2024-03-07

3. Therapeutic Potential of 1,8-Dihydroanthraquinone Derivatives for Breast Cancer;International Journal of Molecular Sciences;2023-10-31

4. In Silico and In Vitro Studies of Novel Azomethines on DNA Repair Genes in Gastric Cell Lines;Life;2023-09-28

5. Cellular and molecular basis of therapeutic approaches to breast cancer;Cellular Signalling;2023-01